Jean-Philippe Leduc-Gaudet

McGill
5

 

 

 

Elementy, w których Jean-Philippe Leduc-Gaudet attends

poniedziałek 23 listopada, 2020

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
9:30
Decorative image for session Welcome from the director
Welcome from the director
9:30 - 9:45 | 15 min.
9:45
Decorative image for session Session 1: The research of the members
Session 1: The research of the members
9:45 - 11:30 | 1 godz. 45 min.
10:15
Effet de mutations dans la protéine TBC1D24 associée au syndrome DOORS sur la dynamique mitochondriale
10:15 - 11:30 | 1 godz. 15 min.
10:30
Comprendre la réponse positive induite par l’entraînement physique observée chez la population atteinte de dystrophie myotonique de type 1 par la protéomique
10:30 - 11:45 | 1 godz. 15 min.
10:45
Biallelic variants in the transcription factor PAX7 are a new genetic cause of Myopathy
10:45 - 11:00 | 15 min.
11:00
Exploiting the conformational regulation of ELMO proteins reveals that myoblast fusion can be exploited for regenerative therapies in muscle diseases
11:00 - 11:15 | 15 min.
11:30
ALS gene, C9orf72, loss of function Zebrafish model shows motor and synaptic defects
11:30 - 12:30 | 1 godz.
Mitochondria-Derived Vesicles prevent inflammation by controlling the inclusion of mitochondrial proteins into extracellular vesicles
11:30 - 12:30 | 1 godz.
Novel neurodevelopmental genes in C. elegans
11:30 - 12:30 | 1 godz.
Drug repurposing for Duchenne Muscular Dystrophy using phenotype-based drug screening
11:30 - 12:30 | 1 godz.
L’interaction entre progéniteurs fibro-adipogéniques et médiateurs lipidiques, le nouvel orchestre de la régénération musculaire
11:30 - 12:30 | 1 godz.
CLN5 and CLN3 function as a complex to regulate endosome-to-TGN trafficking
11:30 - 12:30 | 1 godz.
Preliminary Results on Novel Gene Involved in Regulating Differentiation of C2C12 Myoblasts
11:30 - 12:30 | 1 godz.
Targeting muscle stem cells as a therapeutic approach for myotonic dystrophy type 1
11:30 - 12:30 | 1 godz.